As of 2026-10-06, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (74.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.02 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -228.4%.
The range of the Relative Valuation is (63.95) - (90.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 24.9x | 21.2x |
| Forward P/E multiples | 14.5x - 25.0x | 19.8x |
| Fair Price | (63.95) - (90.47) | (74.48) |
| Upside | -210.2% - -255.9% | -228.4% |
| Date | P/E |